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Background: Neutral, low-glucose degradation product (GDP) peritoneal dialysis fluid (PDF) is less damaging to the
peritoneum than conventional PDF but is still insufficient for biocompatibility. One remaining issue is the problem
of buffering.
Methods: Using cultured rat peritoneal mesothelial cells (PMCs), the present study examined the difference
between the effects of neutral low-GDP lactate PDF and neutral low-GDP bicarbonate/lactate PDF on cells. The
effects of lactate stimulation on these cells were also examined.
Results: Lactate PDF enhanced mRNA expressions of α-smooth muscle actin (αSMA) and type 1 and type 3
collagens and lowered expression of e-cadherin mRNA in PMCs compared to bicarbonate/lactate PDF. Lactate
stimulation increased mRNA expressions of αSMA, matrix metalloproteinase 2 (MMP2), and basic fibroblast growth
factor (bFGF) and suppressed e-cadherin mRNA expression. Transforming growth factor (TGF)-β1 and TGF-β2 and
collagen type 1 and 3 mRNA expressions were also enhanced by lactate stimulation.
Conclusions: These results suggest that lactate as a PDF buffer may act on PMCs to promote epithelial-
mesenchymal transition (EMT) and production of TGF-β, bFGF, and collagen.
Keywords: Peritoneal dialysis fluid, Buffer, Lactate, Peritoneal mesothelial cell, Epithelial-to-mesenchymal transition,
Fibrosis, Transforming growth factor-β, Basic fibroblast growth factorBackground
Peritoneal dialysis (PD) is an established treatment in renal
replacement therapy, can be performed at home without
bulky equipment, and can maintain a high quality of life.
However, long-term PD treatment causes pathological
changes to the peritoneum, such as detachment of meso-
thelial cells, fibrosis of the interstitium, increases in the
new blood vessels, and narrowing of the vascular cavities
[1]. These changes result in peritoneal dysfunction, making
PD difficult to maintain. The risk of complications such as
encapsulating peritoneal sclerosis due to peritoneal disor-
ders is also increased [2]. To address this problem, a
change has been made from acidic high-GDP PDF to© The Author(s). 2020 Open Access This artic
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peritoneal disorders [3]. However, some problems remain
with the biocompatibility of these new PDFs, with the issue
of buffering representing one such problem. In Japan, all
buffering agents for neutral low-GDP PDF to date have
been lactate, but a bicarbonate/lactate buffer PDF has re-
cently been released. However, few studies have examined
the effects of buffering agents on the peritoneum. This
study investigated the effects of neutral low-GDP PDF
containing different buffers on the peritoneum and further
clarified the effects of lactate on the peritoneum.
Methods
PDF
Dianeal N® (Baxter, Tokyo, Japan) was used as the lactate
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constituents of these two PDFs.Culture of PMCs
The isolation and culture of PMCs were performed
according to our previously reported method [4]. Briefly,
omentum was obtained from the abdominal cavity of
Sprague-Dawley rats and dissolved in 0.05% trypsin and
0.02% ethylenediaminetetraacetate solution at 37 °C for 20
min. Cellular components were then isolated by
centrifugation (150×g, 3 min) and washed with phosphate-
buffered saline (PBS). Cells were suspended in Dulbecco’s
modified Eagle’s medium/Ham’s Nutrient Mixture F12
(DMEM/F12) medium (Thermo Fisher Scientific, Yoko-
hama, Japan) supplemented with 10% fetal bovine serum
(FBS) (Biological Industries, Cromwell, CT), penicillin at 50
U/mL, and streptomycin at 50 μg/mL. Cells were seeded
into 10-cm2 collagen type I-coated Petri dishes at 37 °C
under a 5% CO2/95% air atmosphere. PMCs were identified
by the uniform cobblestone appearance at confluence, by
negative staining for von Willebrand factor, and by positive
staining for both cytokeratin and vimentin. Confluent cul-






e-cadherin-F GAGAGTCGAGGTGCCTGAGGExamination of two different PDFs and two different buffers
Confluent cultured PMCs were divided into 5 groups:
control group, L-PDF group, B/L-PDF group, L group,
and B/L group. The control group used cultured mesothe-
lial cells in DMEM/F12 + 10% FBS. The L-PDF and B/L-
PDF groups used cultured cells in Dianeal N® or Reguneal®
+ 200 mM glutamate (Wako Pure Chemical Industries,
Osaka, Japan) (both with the same content of DMEM/
F12) + 10% FBS. The L and B/L groups used cultured cells
in PBS + 40 mM lactate (Wako Pure Chemical Industries)
or 30 mM NaHCO3 (Wako Pure Chemical Industries)
with 10 mM lactate + 200 mM glutamate + 10% FBS. All
culture media were adjusted to pH 7.0 using HCl. Cells
were stimulated in these media for 72 h.Table 1 Constituents of lactate PDF and bicarbonate/lactate PDF
Lactate PDF Bicarbonate/lactate PDF
pH 6.5–7.5 6.8–7.8
Na (mEq/L) 132 132
Ca (mEq/L) 3.5 3.5
Mg (mEq/L) 0.5 0.5
Cl (mEq/L) 96 100
Lactate (mEq/L) 40 10
HCO3 (mEq/L) – 25
Glucose (w/v%) 1.36 1.36
Plasticizer – –Examination of effects of lactate on PMCs
Confluent cultured PMCs were divided into 6 groups:
control, L5, L10, L20, L40, and L80 groups. The control
group used cultured mesothelial cells in PBS + 200 mM
glutamate with 10% FBS. The L5, L10, L20, L40, and
L80 groups used cultured cells in PBS + 200 mM glu-
tamate with 10% FBS, with the addition of 5 mEq/L, 10
mEq/L, 20 mEq/L, 40 mEq/L, or 80 mEq/L of lactate, re-
spectively. All culture media were adjusted to pH 7.0
using HCl. Cells were stimulated in these media for 6,
24, 48, and 72 h.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted using NucleoSpin RNA
(Macherey-Nagel, Düren, Germany) according to the in-
structions from the manufacturer. The cDNA was con-
structed with a SuperScript III for RT-PCR kit (Thermo
Fisher Scientific, Yokohama, Japan). For amplification,
qRT-PCR reaction solutions used 50 ng of cDNA, 10
μM of each primer, and 10 μL of FastStart Universal
SYBR Green Master (Roche Molecular Diagnostics,
Rotkreuz, Switzerland) in a volume of 38 μL with 30–35
cycles of 15 s at 95 °C and 15 s at 60 °C. Primer se-
quences are indicated in Table 2. The mRNA expression
of each gene was represented by the ratio to GAPDH
mRNA expression.
Statistical analysis
Data are presented as mean ± standard deviation. All
statistical analyses were performed using the Kruskal-e-cadherin-R TCCAAATCCGATACGTGATCTTCTG
MMP2-F GGGACAAGTTCTGGAGATACAATGA
MMP2-R ACTTCACACTCTTCAGACTTTGGT






Collagen type 1-F AGCCTACATGGACCAACAGACT
Collagen type 1-R CAAGTTCCGGTGTGACTCGTG
Collagen type 3-F CTAGAGGATGGCTGCACTAAACAC
Collagen type 3-R TCTATGATGGGGAGTCTCATGGC
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honestly significant difference test on JMP Pro version
14.0 software (SAS Institute Japan, Tokyo, Japan). Values
of P < 0.05 were considered significant.
Results
Effects of two different PDFs and buffers on PMCs
Expressions of mRNAs for αSMA and collagen types 1
and 3 were higher in the L-PDF group than in the con-
trol group. Expression of e-cadherin mRNA was lowerFig. 1 Examination of two different PDFs and two different buffers on PMC
and collagen type 3 (d). *P < 0.01 vs control, **P < 0.05 vs control,※P < 0.0
and L groups, αSMA, collagen type 1, and collagen type 3 mRNA expressio
compared with the control group. The B/L-PDF group and B/L group showin the L-PDF group than in the control group. However,
in the B/L-PDF group, expressions of αSMA, e-cadherin,
and collagen type 3 mRNAs did not differ significantly
from those of controls. All gene expressions in the B/L
PDF group were significantly different from those in the
L-PDF group. Similarly, mRNA expressions of these
genes in the L group were significantly different from
those in the control group, but changes in mRNA ex-
pressions for the B/L group were small and differed from
those in the L group (Fig. 1).s. mRNA expression of αSMA (a), e-cadherin (b), collagen type 1 (c),
5 vs L-PDF, #P < 0.05 vs L-group, ##P < 0.01 vs L-group. In the L-PDF
ns were enhanced and e-cadherin mRNA expression was decreased as
ed the same levels of expression of these genes as the control group
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Changes in each gene expression for the L5–L80 groups
according to the stimulation time of 6–72 h are repre-
sented as the ratio to gene expression in the control
group. Expressions of all genes showed significant inter-
actions between the dose factor of lactate and the factor
of stimulation time. Multiple differences were thus used
to examine differences in stimulus time for each stimu-
lus dose of 5–80 mEq/L and the difference in dose for
each stimulus time (6–72 h). Gene expressions for each
group are shown in Figs. 2, 3, and 4 for each stimulation
time and each stimulation dose.
Expression of e-cadherin mRNA decreased in a dose-
dependent manner after 24, 48, and 72 h of stimulation
with lactate (Fig. 2a). In the L20, L40, and L80 groups,
mRNA expression decreased more with increasing
stimulation time (Fig. 2d).
Dose- and time-dependent upregulations of αSMA
mRNA expression were recognized after 48 and 72 h ofFig. 2 Effects of lactate on EMT of PMCs. Levels of mRNA expression for e-
control group, L5 group, L10 group, L20 group, L40 gro
group. ***P < 0.001 vs control, #P < 0.0001 vs control group. Levels of mRN
stimulus dose: 6 h, 24 h, 48 h, 72 h. *P < 0.05 vs 6 h. **P
mRNA decreased (a, d) and αSMA mRNA expression increased (b, e) depen
was stimulated at 48 and 72 h with 80 mEq/L (c, f)stimulation (Fig. 2b, e). MMP2 mRNA expression
tended to decrease with dose at 24, 48, and 72 h of
stimulation, but increased with 80 mEq/L and 48 and 72
h of stimulation (Fig. 2c).
Expression of TGF-β1 mRNA was increased in the
L80 group at 48 and 72 h after stimulation, but no
increases were seen in the other groups (Fig. 3a).
TGF-β2 mRNA expression tended to increase with in-
creasing dose at 24 h stimulation, but no changes
were seen for other stimulation times except with 80
mEq/L stimulation (Fig. 3b). In the L80 group, TGF-
β2 mRNA expression was increased at 24 and 72 h
after stimulation (Fig. 3e).
Expression of bFGF mRNA was accelerated in a dose-
dependent manner (Fig. 3c) and increased in a time-
dependent manner in the L80 group (Fig. 3f).
Expression of collagen type 1 and 3 mRNA also tended
to increase dose- and time-dependently with lactate
stimulation (Fig. 4).cadherin (a), αSMA (b), and MMP-2 (c) with each stimulus time:
up, L80 group, *P < 0.05 vs control group, **P < 0.01 vs control
A expression for e-cadherin (d), αSMA (e), and MMP-2 (f) with each
< 0.01 vs 6 h. ***P < 0.001 vs 6 h. #P < 0.0001 vs 6 h. E-cadherin
ding on lactate dose and stimulation time. MMP2 mRNA expression
Fig. 3 Effects of lactate on TGF-β and bFGF mRNA expressions of PMCs. Levels of mRNA expression for TGF-β1 (a), TGF-β2 (b), and bFGF (c) for
each stimulus time: control group, L5 group, L10 group, L20 group, L40 group, L80 group. **P < 0.01 vs control
group. ***P < 0.001 vs control group.#P < 0.0001 vs control group. Levels of mRNA expression for TGF-β1 (d), TGF-β2 (e), and bFGF (f) with each
stimulus dose: 6 h, 24 h, 48 h, 72 h. *P < 0.05 vs 6 h. **P < 0.01 vs 6 h. ***P < 0.001 vs 6 h. #P < 0.0001 vs 6 h. TGFβ1 mRNA
expression tended to be enhanced upon stimulation with 80 mEq/L (d). TGFβ2 mRNA expression was upregulated in a dose-dependent manner
(e). Expression of bFGF mRNA was upregulated in a dose- and time-dependent manner (c, f)
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In the peritoneum of long-term PD patients, mesothelial
cells degenerate and disappear, and interstitial fibrotic
thickness and neovascularization have been reported [5].
These changes were affected by the PDF, and recogni-
tion of this fact led to the development of a biocompat-
ible, neutral, low-GDP PDF. Many reports have shown
that this new PDF results in less damage to the periton-
eum than conventional acidic high-GDP PDF [3, 6, 7].
However, even this neutral, low-GDP PDF does not pre-
vent all pathological changes to the peritoneum [8]. One
of the causes is considered to be the effect of the buffer.
Various reports have examined the effect of the buffer in
PDF on the peritoneum, but most such studies have in-
volved comparisons between conventional lactate PDF
as a high-GDP PDF and neutral bicarbonate/lactate PDF
as a low-GDP PDF [9–11]. Differences in the effects of
these dialysates on the peritoneum, thus cannot be
attributed to the buffer alone.In Japan, neutral, low-GDP lactate PDF has been on
the market for about 15 years, and all glucose dialysates
have now been replaced with this solution. In addition
to neutral, low-GDP lactate PDF, neutral low-GDP bi-
carbonate/lactate PDF was recently launched in Japan.
The effect of the buffer in the PDF on the peritoneum
was considered able to be examined by comparing these
two PDFs. In the present study, the L-PDF group
showed higher expression of αSMA and type 1 and 3
collagen mRNA and lower expression of e-cadherin
mRNA in PMCs compared to the B/L-PDF PDF group.
These phenomena were also observed in comparisons
between the L-group and B/L group. Based on these
results, lactate PDF may enhance EMT formation and
collagen production by PMCs.
One report used the same two PDFs we used and
found that bicarbonate/lactate PDF was less toxic to cell
viability and apoptosis of PMCs than lactate PDF [12].
In addition, a clinical study [13] reported that Fibrin
Fig. 4 Effects of lactate on collagen genes. a Expressions of collagen type 1 mRNA for each stimulus time. b Expressions of collagen type 3
mRNA for each stimulus time control group, L5 group, L10 group, L20 group, L40 group, L80 group. **P < 0.01 vs
control group. ***P < 0.001 vs control group. #P < 0.0001 vs control group. c Expression of collagen type 1 mRNA for each stimulus dose. d
Expression of collagen type 3 mRNA for each stimulus dose: 6 h, 24 h, 48 h, 72 h. *P < 0.05 vs 6 h. **P < 0.01 vs 6 h. #P <
0.0001 vs 6 h. Increased expression of collagen type 1 mRNA was observed in dose- and time-dependent manners (a, c). Increased expression of
collagen type 3 mRNA was observed upon stimulation with lactate at 40 and 80 mEq/L (b, d)
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factor concentrations in effluent were lower when using
bicarbonate/lactate PDF than when using lactate PDF.
From our results and those reports, we consider that
bicarbonate/lactate PDF may result in less peritoneal
damage than lactate PDF.
We next examined the effects of lactate on EMT and
collagen production in PMCs. Lactate decreased e-
cadherin mRNA expression and increased αSMA mRNA
expression in a dose- and time-dependent manner.
MMP2 mRNA expression was increased with 80 mEq/Llactate at 48 and 72 h of stimulation. Increases in ex-
pressions of αSMA and MMP2 mRNAs and decreases in
e-cadherin mRNA expression are phenomena occurring
in EMT [14], suggesting that lactate may promote EMT
in PMCs.
In this study, lactate at high doses promoted TGF-β1
and TGF-β2 mRNA expressions. In addition, bFGF
mRNA expression was accelerated in dose- and time-
dependent manners by lactate stimulation. Few studies
have examined the effects of buffer alone on peritoneal
cells [15, 16]. Ogata et al. [15] reported the effects of
Higuchi et al. Renal Replacement Therapy            (2020) 6:61 Page 7 of 8lactate, bicarbonate/lactate, and bicarbonate on human
mesothelial cells, fibroblasts, and vascular endothelial
cells. They showed that the highest amount of bFGF was
produced by lactate, followed in order by bicarbonate/
lactate and bicarbonate. They concluded that lactate acts
on PMCs to increase bFGF production. Our results also
showed that lactate increased expression of bFGF
mRNA, similar to their results. TGF-β and bFGF are
known facilitators of EMT [17]. Our results suggest that
lactate may activate TGF-β and bFGF production and
cause EMT.
Expressions of collagen type 1 and type 3 mRNAs
were also stimulated in dose- and time-dependent man-
ners by lactate. EMT is greatly involved in tissue fibrosis,
and lactate may cause EMT in PMCs to increase colla-
gen production and promote peritoneal fibrosis.
Many papers have described lactate produced by lac-
tate dehydrogenase as triggering EMT in several cancer
cells [18–20]. Several studies have also examined the re-
lationships between lactate, EMT, and fibrosis [21–23].
In those reports, lactate was considered to enhance the
production of TGF-β, leading to enhanced EMT and
collagen production. Among these studies, Kottmann
et al. [21, 22] attributed the lactate-enhancing effects of
EMT to the low pH, whereas Zareie et al. [24] showed
that lactate PDF was associated with stronger angiogen-
esis and enhanced fibrosis regardless of pH. They con-
cluded that the action of lactate was unrelated to pH.
Our experiments standardized the pH at 7.0 to remove
the need to account for the effects of pH. As a result,
lactate was seen to increase EMT, TGF-β, bFGF, and
collagen production. We therefore believe that these ef-
fects are unrelated to pH, with lactate itself leading to
the promotion of EMT, promotion of collagen produc-
tion, and peritoneal fibrosis. In this study, only mRNA
expressions were measured as markers for the effects of
lactate on EMT and collagen expressions, but measure-
ment at the protein level is also necessary, and such
studies are planned for the future. Signal pathways that
cause EMT of TGFβ and bFGF have been known to in-
volve smad2/3 and snail. We believe that further re-
search about signal pathways including smad2/3 and
snail is needed on this point.
In the experiment that changed the dose and timing of
lactate and examined mRNA expressions of MMP2,
TGFβ1, and collagen type 3, no significant increases were
observed with 40 mEq/L lactate alone, but only at 80
mEq/L. However, changes in EMT and fibrotic mRNA
were observed by stimulation with PDF containing 40
mEq/L lactate. We considered that these differences may
be influenced by the GDP contained in PDF, as even neu-
tral PDF contains GDP, albeit at low concentrations. We
hope to investigate in closer detail the effects of 40 mEq/L
lactate + GDP on mesothelial cells in the future.In the mechanism of peritoneal fibrosis, mesothelial
cells have been considered an important source of myo-
fibroblasts through the EMT. However, Chen et al. [25]
reported that submesothelial fibroblasts are major pre-
cursors of peritoneal myofibroblasts using an in vivo
model. Lua et al. [26] have been pointed out that only
17% of myofibroblasts were derived from mesothelial
cells in peritoneal fibrosis. The fibrogenic cells have not
been identified with certainly. We think further consid-
eration is needed in this regard.Conclusions
Lactate PDF enhanced expressions of αSMA and colla-
gen mRNA and lowered expression of e-cadherin
mRNA in peritoneal mesothelial cells more strongly
than lactate/bicarbonate PDF. Lactate showed an
EMT-promoting effect and TGFβ, bFGF, and collagen
production-enhancing effects on mesothelial cells.
These results suggest that lactate in PDF may have
harmful effects on PMCs.
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